Skip to main content

Schizophrenia

Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices.
Q&A
Christoph Correll, MD, and Sanjai Rao, MD, respond to questions asked by attendees of a Psych Congress 2020 session they presented on managing weight gain and metabolic disruptions in patients with schizophrenia.
YOUR QUESTIONS ANSWERED
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the use of long-acting injectables for patients with dementia and paranoia or other delusions.
Videos
In this video from Psych Congress 2020, Sanjai Rao, MD, discusses whether imaging data could play a role in diagnosing schizophrenia.
Q&A
Laura J. Fochtmann, MD, MBI, shares insights on a new set of evidence-based practice guidelines for the treatment of patients with schizophrenia, which she helped write.
Videos
In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.
VIDEO
In this video, psychiatrist Ilan Melnick, MD, discusses the transition of care of patients with serious mental illness such as schizophrenia, including the difficulties such patients face, how mental health clinicians can aid in the transition, and the benefits of using long-acting injectables.
PODCAST
In this podcast, Jonathan Meyer, MD, discusses the role of D2 antagonism in schizophrenia treatment, lessons learned about schizophrenia treatment from clozapine, and emerging treatments for schizophrenia and their therapeutic targets.
VIDEO
In this video, Christoph U. Correll, MD, of Hofstra/Northwell in New York, discusses the possible clinical applications of the combination of olanzapine and the mu-opioid antagonist samidorphan.
VIDEO
In this video, Christoph U. Correll, MD, discusses additional research needed on the combination of olanzapine and the mu-opioid antagonist samidorphan.
VIDEO
Christoph U. Correll, MD, discusses the results of the ENLIGHTEN‑2 study, which compared weight gain and cardiometabolic side effects in patients taking olanzapine and patients taking olanzapine plus samidorphan.
Back to Top